FDA Safety Changes: Reclast, Celestone Soluspan, Cymbalta
This is a discussion on FDA Safety Changes: Reclast, Celestone Soluspan, Cymbalta within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; The FDA has approved revisions to the safety labeling for zoledronic acid infusion, betamethasone acetate plus betamethasone sodium phosphate injection, ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
09-24-2008, 02:20 PM
|
|||
|
|||
FDA Safety Changes: Reclast, Celestone Soluspan, Cymbalta
The FDA has approved revisions to the safety labeling for zoledronic acid infusion, betamethasone acetate plus betamethasone sodium phosphate injection, and duloxetine delayed-release capsules.
Medscape Medical News More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Cymbalta in non-diabetic neuropathy | participant2 | Managed Care Issues for Oral Drugs | 1 | 02-20-2008 06:45 PM |
© 2008 DrugManagementForum™ powered by |
 |